Christoph Licht

13.0k total citations
177 papers, 4.9k citations indexed

About

Christoph Licht is a scholar working on Immunology, Nephrology and Hematology. According to data from OpenAlex, Christoph Licht has authored 177 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 99 papers in Immunology, 90 papers in Nephrology and 57 papers in Hematology. Recurrent topics in Christoph Licht's work include Complement system in diseases (96 papers), Renal Diseases and Glomerulopathies (78 papers) and Adenosine and Purinergic Signaling (21 papers). Christoph Licht is often cited by papers focused on Complement system in diseases (96 papers), Renal Diseases and Glomerulopathies (78 papers) and Adenosine and Purinergic Signaling (21 papers). Christoph Licht collaborates with scholars based in Canada, United States and Germany. Christoph Licht's co-authors include Peter F. Zipfel, Christine Skerka, Stefan Heinen, Mihály Józsi, Damien Noone, Fred G. Pluthero, Magdalena Riedl, Bernd Höppe, Heiko Richter and Aoife Waters and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Christoph Licht

165 papers receiving 4.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christoph Licht Canada 38 3.1k 2.4k 1.3k 666 561 177 4.9k
Fádi Fakhouri France 48 4.4k 1.4× 4.2k 1.8× 1.8k 1.3× 1.2k 1.8× 1.2k 2.2× 180 7.9k
Antonio M. Risitano Italy 48 5.6k 1.8× 2.5k 1.0× 3.5k 2.7× 812 1.2× 1.9k 3.5× 200 8.1k
Timothy H.J. Goodship United Kingdom 47 5.9k 1.9× 4.6k 1.9× 2.6k 2.0× 875 1.3× 1.0k 1.8× 140 8.5k
Sonata Jodele United States 42 2.5k 0.8× 1.0k 0.4× 1.7k 1.3× 489 0.7× 515 0.9× 171 5.1k
Johanna A. Kremer Hovinga Switzerland 45 5.3k 1.7× 2.6k 1.1× 3.4k 2.6× 429 0.6× 2.0k 3.6× 173 7.0k
Paul Coppo France 42 5.6k 1.8× 2.3k 1.0× 4.0k 3.0× 520 0.8× 1.8k 3.3× 248 7.9k
Han‐Mou Tsai United States 32 4.4k 1.4× 2.1k 0.9× 3.2k 2.4× 270 0.4× 1.5k 2.8× 72 5.6k
Ryotaro Nakamura United States 41 2.3k 0.8× 571 0.2× 3.0k 2.3× 556 0.8× 1.0k 1.8× 219 5.6k
Chantal Loirat France 61 6.5k 2.1× 5.4k 2.2× 2.7k 2.0× 1.5k 2.2× 1.3k 2.2× 202 10.8k
Hubert Nivet France 28 890 0.3× 1.0k 0.4× 439 0.3× 581 0.9× 211 0.4× 99 3.1k

Countries citing papers authored by Christoph Licht

Since Specialization
Citations

This map shows the geographic impact of Christoph Licht's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christoph Licht with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christoph Licht more than expected).

Fields of papers citing papers by Christoph Licht

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christoph Licht. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christoph Licht. The network helps show where Christoph Licht may publish in the future.

Co-authorship network of co-authors of Christoph Licht

This figure shows the co-authorship network connecting the top 25 collaborators of Christoph Licht. A scholar is included among the top collaborators of Christoph Licht based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christoph Licht. Christoph Licht is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Robinson, Cal, Tonny Banh, Rahul Chanchlani, et al.. (2025). Comparative Efficacy of Nonsteroid Immunosuppressive Medications in Childhood Nephrotic Syndrome. JAMA Pediatrics. 179(3). 321–321. 3 indexed citations
2.
Gale, Daniel P., Andrew S. Bomback, Christoph Licht, et al.. (2025). #3391 Pegcetacoplan treatment appears to halt disease progression in C3G and primary (idiopathic) IC-MPGN patients: results from the phase 3 VALIANT study. Nephrology Dialysis Transplantation. 40(Supplement_3). 1 indexed citations
3.
Robinson, Cal, Tonny Banh, Christoph Licht, et al.. (2025). Challenging Clinical Practice Guideline Definitions in Childhood Nephrotic Syndrome. Clinical Journal of the American Society of Nephrology. 20(12). 1767–1779.
4.
Robinson, Cal, Tonny Banh, Rahul Chanchlani, et al.. (2024). Prolonged remission after cyclophosphamide or tacrolimus treatment in childhood nephrotic syndrome: a cohort study. Pediatric Nephrology. 40(5). 1625–1634. 3 indexed citations
5.
Grunebaum, Eyal, Binita M. Kamath, Christoph Licht, et al.. (2023). Case report: A case of spinal muscular atrophy in a preterm infant: risks and benefits of treatment. Frontiers in Neurology. 14. 1230889–1230889. 9 indexed citations
6.
Ranchin, Bruno, Claus Peter Schmitt, Bradley A. Warady, et al.. (2023). Devices for long-term hemodialysis in small children—a plea for action. Kidney International. 103(6). 1038–1040. 9 indexed citations
7.
Halimi, Jean‐Michel, Imad Al‐Dakkak, Gianluigi Ardissino, et al.. (2022). Clinical characteristics and outcomes of a patient population with atypical hemolytic uremic syndrome and malignant hypertension: analysis from the Global aHUS registry. Journal of Nephrology. 36(3). 817–828. 13 indexed citations
8.
Remuzzi, Giuseppe, Bradley P. Dixon, Fádi Fakhouri, et al.. (2022). POS-048 PHASE 3, RANDOMIZED, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF PEGCETACOPLAN IN TREATMENT OF C3G OR IC-MPGN. Kidney International Reports. 7(6). S459–S459. 2 indexed citations
9.
Chiang, Kuang‐Yueh, Tal Schechter, Muhammad Ali, et al.. (2021). Peripheral venous catheter collection of immune effector cells and hematopoietic stem cells is feasible and safe in older pediatric patients. Transfusion. 61(12). 3413–3419. 1 indexed citations
10.
Gnannt, Ralph, Damien Noone, Christoph Licht, et al.. (2020). Hemodialysis Catheters in Infants: A Retrospective Single-Center Cohort Study. Journal of Vascular and Interventional Radiology. 31(5). 778–786. 7 indexed citations
11.
Greenbaum, Larry A., Christoph Licht, Vasileios S. Nikolaou, et al.. (2020). Functional Assessment of Fatigue and Other Patient-Reported Outcomes in Patients Enrolled in the Global aHUS Registry. Kidney International Reports. 5(8). 1161–1171. 11 indexed citations
12.
Banh, Tonny, Jovanka Vasilevska‐Ristovska, Neesha Hussain‐Shamsy, et al.. (2019). Association of low birth weight and prematurity with clinical outcomes of childhood nephrotic syndrome: a prospective cohort study. Pediatric Nephrology. 34(9). 1599–1605. 12 indexed citations
13.
Jacobs, Erin C., et al.. (2018). Skeletal muscle injury and repair: A role for complement. Molecular Immunology. 102. 165–165.
14.
Licht, Christoph, Larry A. Greenbaum, Petra Muus, et al.. (2015). Efficacy and safety of eculizumab in atypical hemolytic uremic syndrome from 2-year extensions of phase 2 studies. Kidney International. 87(5). 1061–1073. 296 indexed citations
15.
Chaturvedi, Swasti, et al.. (2014). Pharmacological interventions for hypertension in children. Cochrane Database of Systematic Reviews. 2014(2). CD008117–CD008117. 37 indexed citations
16.
Hayes, Wesley, Sibylle Tschumi, Simon C. Ling, et al.. (2014). Eculizumab hepatotoxicity in pediatric aHUS. Pediatric Nephrology. 30(5). 775–781. 35 indexed citations
17.
Hooper, David K., Adam C. Carle, Sandra Amaral, et al.. (2013). The quality of cardiovascular disease care for adolescents with kidney disease: a Midwest Pediatric Nephrology Consortium study. Pediatric Nephrology. 28(6). 939–949. 16 indexed citations
18.
Noone, Damien, Kathryn Tinckam, Peter F. Zipfel, et al.. (2012). Antibody Mediated Rejection Associated With Complement Factor H–Related Protein 3/1 Deficiency Successfully Treated With Eculizumab. American Journal of Transplantation. 12(9). 2546–2553. 52 indexed citations
19.
Chaturvedi, Swasti, Leonardo R. Brandão, Denis F. Geary, & Christoph Licht. (2011). Primary antiphospholipid syndrome presenting as renal vein thrombosis and membranous nephropathy. Pediatric Nephrology. 26(6). 979–985. 6 indexed citations
20.
Dienes, Hans‐Peter, et al.. (2007). Endothelin-1 Induces NF-κB via Two Independent Pathways in Human Renal Tubular Epithelial Cells. American Journal of Nephrology. 27(3). 294–300. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fádi Fakhouri Breakdown of academic impact, for papers by Antonio M. Risitano Breakdown of academic impact, for papers by Timothy H.J. Goodship Breakdown of academic impact, for papers by Sonata Jodele Breakdown of academic impact, for papers by Johanna A. Kremer Hovinga Breakdown of academic impact, for papers by Paul Coppo Breakdown of academic impact, for papers by Han‐Mou Tsai Breakdown of academic impact, for papers by Ryotaro Nakamura Breakdown of academic impact, for papers by Chantal Loirat Breakdown of academic impact, for papers by Hubert Nivet
Rankless by CCL
2026